Kelly Scott A. 4
4 · CytoDyn Inc. · Filed Oct 20, 2021
Insider Transaction Report
Form 4
CytoDyn Inc.CYDY
Kelly Scott A.
Director
Transactions
- Award
Non-qualified Stock Option
2021-10-18+1,750,000→ 1,750,000 totalExercise: $1.39Exp: 2031-10-18→ Common Stock (1,750,000 underlying)
Footnotes (1)
- [F1]The options will vest in 3 equal annual installments beginning on August 6, 2022, subject to Continuous Service (as defined in the Issuer's 2012 Equity Incentive Plan, as amended) through the applicable vesting date.